Q3 2025 Earnings Call Transcript November 10, 2025 FibroGen, Inc. beats earnings expectations. Reported EPS is $-1.61, ...
In a historic move, the U.S. Food and Drug Administration has removed the decades-old "black box" warning from vaginal estrogen products. This action does more than restore prescribing freedom?it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback